Sensorion (STU:RFM0) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:RFM0 Sensorion SA STU:RFM0
37 GF Score
Price €11.40
GF Value €0.43
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Sensorion Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:RFM0 vs VRTX, REGN, MRNA: Short Interest Comparison

For the Biotechnology subindustry, Sensorion's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sensorion Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sensorion's Short Interest distribution charts can be found below:

* The bar in red indicates where Sensorion's Short Interest falls into.


STU:RFM0
37GF Score
Sensorion SA STU:RFM0
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sensorion (STU:RFM0) Overvalued in 2026?

Based on GuruFocus' analysis, Sensorion stock appears to be overvalued. The current stock price of €11.40 is trading 2551.2% above its estimated GF Value™ of €0.43. GuruFocus considers Sensorion to be Significantly Overvalued.

Key valuation signals for STU:RFM0:

  • Short Interest:
  • GF Value™: €0.43 vs. price of €11.40 (2551.2% above fair value)
  • GF Score™: 37/100 with 1 warning sign

No single metric tells the full story. See the STU:RFM0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sensorion Business Description

Other Exchanges ALSEN:France
Address 375, rue du Professeur Joseph Blayac, Montpellier, FRA, 34080
Sensorion SA is a France-based clinical-stage biotech company, which specializes in the development of novel therapies to restore, treat, and prevent hearing loss disorders. The SENS501 (OTOF-GT) targets deafness caused by mutations of the gene encoding for otoferlin and is currently developed in a Phase 1/2 clinical study, and GJB2-GT targets hearing loss related to mutations in GJB2 gene to potentially address important hearing loss segments in adults and children. The Company is also working on the identification of biomarkers to improve diagnosis of these underserved illnesses. The company's pipeline programs are OTOF-GT (SENS-501), GJB2-GT, GJB2-GT, GJB2-GT, TREAT AND PREVENT, SENS-401 COCHLEAR, SENS-401 CIO, and SENS-401 SSNHL.
37GF Score

Get the complete analysis for STU:RFM0

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.40
Price
€0.43
GF Value